recent articles
Proscia discusses what's in store for Concentriq for Research. Digital and computational pathology are transforming the R&D value chain – from discovery to market. As the trusted leader in life sciences, Concentriq for Research has...
Proscia: Pathology’s transition from glass slides to digital images has opened a huge frontier, enabling the application of artificial intelligence (AI) to improve everything from workflow efficiency to patient outcomes. However, developing...
Proscia: Retrospective study demonstrated 56.3% increase in melanoma detection sensitivity through use of contrastive self-supervised learning PHILADELPHIA – November 15, 2022 – Proscia®, a leading provider of digital and computational...
Proscia: Findings illustrate promise of technology to lower misdiagnosis rate for deadliest form of skin cancer PHILADELPHIA – November 1, 2022 – Proscia®, a leading provider of digital and computational pathology solutions, has released...
Proscia Flagship software platform helps keep pace with rising demand for pathology services as labor shortage intensifies PHILADELPHIA – October 12, 2022 – Proscia®, a leading provider of digital and computational pathology solutions,...
Proscia: The diagnostic services provider projects DermAI may decrease turnaround time for melanoma cases by 30-40%. GENEVA and PHILADELPHIA – September 14, 2022 – Unilabs, a leading diagnostic services provider, and Proscia®, a leading...































